David Kuhlmann, MD
Sleep Medicine · Sedalia, MONPI 1558459925
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.2%), consulting fees and education — rather than concentrated in one kind of arrangement. Harmony Biosciences LLC accounts for 65.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $1,691 and has fallen 52.8% since, to $798 in 2025.
Across 80 payments — averaging $43.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$2K
- Jazz Pharmaceuticals Inc.$472
- ZOLL Respicardia, Inc.$227
- Axsome Therapeutics, Inc.$175
- Vanda Pharmaceuticals Inc.$74
- Avadel CNS Pharmaceuticals, LLC$61
- plus $211 from 7 others
What the payments were for
- Consulting fees$1,35039%
- Travel & lodging$722%
- Food & beverage$1,95456%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 31 | $2,258 |
| Jazz Pharmaceuticals Inc. | 20 | $472 |
| ZOLL Respicardia, Inc. | 4 | $227 |
| Axsome Therapeutics, Inc. | 9 | $175 |
| Vanda Pharmaceuticals Inc. | 4 | $74 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Resmed Corp | 2 | $44 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Eisai Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wakix$1,497
- remede System$155
- XYWAV$122
How this compares
$3,477 in reported general payments places this provider in the 80th percentile of 33 sleep medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 33 | $569,700 |
| Armodafinil | 35 | $4,890 |
| Modafinil | 45 | $3,237 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 132 | $1,945 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 47 | $1,364 |
| Zolpidem Tartrate | 56 | $831 |
| Ropinirole Hcl | 20 | $569 |
| Clonazepam | 75 | $503 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 13 | $444 |
| Trazodone Hcl | 15 | $147 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Sedalia
- Steven GradneySpringfield$926K
- Raman MalhotraSaint Louis$7K
- David IngramKansas City$7K
- Joseph Roland EspirituSt. Louis$7K
- Rutwik PatelSaint Louis$4K
- Essam ElkadyJoplin$3K
- Oscar SchwartzSaint Louis$3K
- Beth WardChesterfield$2K
- Scott ShortenNorth Kansas City$2K
- Jason MaxfieldJoplin$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.